Application of Super-Resolution Ultrasound (SRUS) in Liver Tumor
NCT07707661 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 350
Last updated 2026-07-16
Summary
The macroscopic vascular supply of liver tumors varies considerably according to histological subtype, lesion size, and disease stage. Current clinical imaging modalities primarily characterize liver tumors based on their macroscopic vascular perfusion patterns. Conventional color Doppler ultrasonography enables qualitative assessment of tumor vascularity, facilitates the differentiation of benign from malignant hepatic lesions, delineates the anatomical relationship between tumors and major intrahepatic vessels, and detects vascular invasion. Nevertheless, these macroscopic vascular characteristics arise from complex microvascular architectures, including vascular distribution patterns, microvessel density, vessel morphology and tortuosity, blood flow velocity, and flow direction. Despite the critical role of tumor microcirculation in tumor progression and therapeutic response, the heterogeneity of microvascular hemodynamics among different liver tumors remains inadequately characterized.
The emergence of Super Resolution Ultrasound Imaging (SRUS) has markedly advanced ultrasound imaging by overcoming the acoustic diffraction limit, enabling visualization of microvessels with diameters as small as approximately 20 μm. Unlike conventional ultrasound techniques, SRUS preserves the inherent advantages of ultrasound, including deep tissue penetration and a large field of view, while achieving an approximately tenfold improvement in spatial resolution. This unique combination effectively bridges the long-standing gap between imaging depth and spatial resolution in vascular imaging. Furthermore, by localizing and tracking individual circulating microbubbles,SRUS enables quantitative assessment of microvascular blood flow velocity over a broad dynamic range without Doppler angle dependence. Consequently, super-resolution ultrasound imaging offers an unprecedented opportunity to characterize and compare the microvascular hemodynamic features of benign and malignant liver lesions, thereby improving the accuracy of preoperative differential diagnosis, tumor staging, therapeutic response assessment, and prognostic evaluation.
Conditions
- Hepatocellular Carcinoma (HCC)
- Intrahepatic Cholangiocellular Carcinoma
- Hepatic Hemangioma
- Focal Nodular Hyperplasia
- Liver Metastasis
Interventions
- DIAGNOSTIC_TEST
-
Perform super-resolution ultrasound imaging on the study population
Perform super-resolution ultrasound imaging on the study population, record and calculate characteristic hemodynamic and morphological parameters, and analyze microvascular flow patterns.
Sponsors & Collaborators
-
Eastern Hepatobiliary Surgery Hospital
lead OTHER
Principal Investigators
-
Hui Liu, Professor · Eastern Hepatobiliary Surgery Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-07-01
- Primary Completion
- 2027-06-01
- Completion
- 2027-09-01
More Related Trials
-
Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma
NCT04847726 ·Status: COMPLETED ·Phase: NA
-
B-mode Ultrasound Imaging in Detecting Early Liver Cancer
NCT02774161 ·Status: COMPLETED ·Phase: NA
-
Hepatocellular Cancer (HCC) Screening in Zhongshan City
NCT02501980 ·Status: UNKNOWN
-
RFA for Small HCC With No-touch Technique and Dual Cooled-Wet Electrode
NCT02806076 ·Status: UNKNOWN ·Phase: NA
-
AI-Guided Surveillance and Curative Salvage of Recurrence After Hepatocellular Carcinoma Resection or Ablation
NCT07732504 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of HCC High Risk Group Using Two Surveillance Tools
NCT02675920 ·Status: COMPLETED
-
Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma
NCT02613156 ·Status: COMPLETED
-
A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer
NCT05371873 ·Status: UNKNOWN
-
Fusing Ultrasound and Magnetic Resonance Imaging to Intelligently Plan Highly Conformal Ablation Thermal Field for Hepatocellular Carcinoma
NCT06798194 ·Status: NOT_YET_RECRUITING
-
To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma
NCT02074202 ·Status: UNKNOWN ·Phase: PHASE3
-
Intravascular Ultrasound for Hepatocellular Carcinoma Staging
NCT00474734 ·Status: UNKNOWN
-
Evaluation of Performance of Automatic Fusion for Radiofrequency Ablation of Hepatocellular Carcinoma
NCT02705118 ·Status: COMPLETED ·Phase: NA
-
Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis
NCT06994130 ·Status: NOT_YET_RECRUITING
-
The Overall Survival of Patients With Unresectable HCC in Real-life
NCT03612726 ·Status: RECRUITING
-
Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk
NCT06312826 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Irreversible Electroporation for Inoperable Hepatic and Pancreatic Malignancy
NCT02822716 ·Status: TERMINATED ·Phase: NA
-
Comparison of the Therapeutic Efficacy of Non-touch Microwave Ablation, Tumor-puncture Microwave Ablation and Surgical Resection for Subcapsular Hepatocellular Carcinoma
NCT07748481 ·Status: NOT_YET_RECRUITING
-
Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma
NCT00842647 ·Status: UNKNOWN
-
Head-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan City
NCT07010198 ·Status: RECRUITING
-
Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC
NCT05433701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Microwave Ablation Versus Laparoscopic Hepatectomy for 3-5cm Hepatocellular Carcinoma
NCT05796700 ·Status: COMPLETED ·Phase: NA
-
The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular Carcinoma
NCT03793322 ·Status: UNKNOWN ·Phase: PHASE1
-
A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma
NCT07368023 ·Status: NOT_YET_RECRUITING
-
Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
NCT06265350 ·Status: RECRUITING ·Phase: NA
-
Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCC
NCT02535117 ·Status: UNKNOWN ·Phase: PHASE4